Skip to content
Trial Eligibility
Menu

Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

NCT03478826

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Interstitial Lung Disease

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
Mayo Clinic
Last updated on ClinicalTrials.gov
April 29, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Minnesota · 1

  • Mayo Clinic · Rochester, MN

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.